Found: 14
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2026 · pp. 24–33
Lapkina E.Z., Zinchenko I.S., Bondar Е.I., Ruksha T.G.
Introduction. Cancer drug resistance is driven among others, by non-genetic mechanisms. These processes may involve transcription factors dysregulation, modifications in gene expression, as well as epigenetic mechanisms such as DNA methylation, histone modific…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2024 · pp. 38–44
Lapkina E.Z., Kutsenko V.A., Ruksha T.G.
Introduction. Cancer cell drug resistance in melanoma is associated with evasion of apoptosis-induced stimuli. Assessing the level of expression of the BCL2 and SIRT1 genes in distant organs and the tumor node makes it possible to assess the resistance of mela…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2023 · pp. 27–35
Vinogradova T.I., Esmedlyayeva D.S., Dyakova M.E., Muravyev A.N., Remezova A.N., Ariel B.M., Bogdanova E.O., Dogonadze M.Z., Zabolotnykh N.V., Yudintseva N.Yu., Polyakova V.O., Yablonskiy P.K.
Introduction. The use of mesenchymal stem cells (MSCs) is recognized as a promising direction for the treatment of diseases with a predominance of inflammation and sclerosis in the pathogenesis, which includes nephrotuberculosis (NT). Target. Studying the effe…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2023 · pp. 51–57
Esmedlyaeva D.S., Alekseeva N.P., Dyakova M.E.
Introduction. The search for molecular markers of adverse treatment outcomes in individuals with pulmonary tuberculosis (PT) is relevant due to the worldwide increase in drug resistance of Mycobacterium tuberculosis (MBT) strains to anti-tuberculosis drugs (PT…
ОБЗОР2023 · pp. 3–10
Okladnikova E.V., Zinchenko I.S., Ruksha T.G.
Introduction. Overcoming resistance to anticancer drugs in the treatment of malignant neoplasms is an urgent problem of recent decades. Unfortunately, there is no single mechanism for the development of resistance. Alterations that occur in a normal cell durin…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2023 · pp. 43–49
Kudriashov G.G., Nefedov A.O., Tochilnikov G.V., Zmitrichenko Yu.G., Krylova Yu.S., Dogonadze M.Z., Gavrilov P.V., Azarov A.A., Davydenkova E.A., Vinogradova T.I., Yablonskii P.K.
Introduction. One of the problems of modern medicine is the low efficiency of treatment of patients with a coexistence of lung cancer and active tuberculosis. Optimal treatment regimens for coexistence pathology have not been developed at present. In recent ye…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2022 · pp. 39–43
Lapkina E.Z., Esimbekova A.R., Zinchenko I.S., Ruksha T.G.
Introduction. A transition of proliferating cancer cells to a G0 phase of a cell cycle considered to be implicated in cancer cell drug resistance. The aim of the study. A separation of G0-positive melanoma B16 cells fraction that correspond to resting followed…
ОБЗОР2022 · pp. 18–27
Tuberculosis remains one of the leading causes of death from infectious diseases in the world. According to WHO data, tuberculosis is diagnosed annually in more than 100 million people and causes 4.5 thousand deaths. Despite a steady decline in the main epidem…
ОБЗОР2021
Mironova E.S., Novak-Bobarykina U.A., Pal’cev M.A., Yablonskiy P.K., Sokolovich E.G., Kvetnoy I.M.
Lung cancer occupies the leading position in at the structure of oncological morbidity in the developed countries. The overall five-year survival rate for lung cancer isn’t exceed to 10–20% even using of the entire modern arsenal of therapeutic methods. Multip…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2016
Sin’kov V.V., Ogarkov O.B., Mokrousov I.V., Zhdanova S.N.
Introduction. Russian population of Mycobacterium tuberculosis includes both highly virulent and less virulent strains; the Ural genotype makes an example of the latters. The aim of study was investigation of the most significant synonymous and non-synonymous …
ОБЗОР2016
Chubarova S.V., Yakovchuk I.А., Kraposhina А.Yu., Soloveva I.A., Demko I.V., Salmina A.B.
The main purpose of the treatment of bronchial asthma is achievement and maintenance of the control over the symptoms of disease at optimal level. For this purpose in terms of basic therapy there is used inhalation of as glucocorticosteroids as well systemic g…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2015
Ludannyy R.I., Alvarez Figueroa M.V., Prokopenko A.V., Valdokhina A.V., Shipulin G.A.
Introduction. The phenomenon of drug resistance of Mycobacterium tuberculosis complex is extremely complicated. The determination of the genetic changes is not always able to explain reasons of this effect clearly. The aim of the study. Molecular genetic analy…
Research article2014
Urazova O.I., Khasanova R.R., Esimova I.E., Novitsky V.V., Churina E.G., Kononova T.E.
Introduction. Disorders in anti-TB immunity may be formed at the stage of interaction between antigen-presenting cells and T-lymphocytes by means of cytokines and their receptors. The key cytokines of T-lymphocyte activation are interleukins (IL) of the IL12 f…
Research article2012
Moskaleva E.Yu., Severin S.E.
In this review the recent data regarding cancer stem cells (CSCs), the mechanisms of their drug resistance and the development of novel anti-CSC therapies are summarized. Recent studies suggest that salinomycin has selective toxicity for CSCs. Salinomycin is a…